- The Potential Immune-Eliciting Cancer Testis Antigens in Colorectal Cancer
Joanne Ern Chi Soh et al, 2018, Immunotherapy CrossRef - Challenges and exploration for immunotherapies targeting cold colorectal cancer
Dan-Dan Li et al, 2023, World Journal of Gastrointestinal Oncology CrossRef - NY-ESO-1 autoantibody as a tumor-specific biomarker for esophageal cancer: screening in 1969 patients with various cancers
Yoko Oshima et al, 2016, Journal of Gastroenterology CrossRef - Optimization of norovirus virus‐like particle production in Pichia pastoris using a real‐time near‐infrared bioprocess monitor
Stephanie A. Parker et al, 2016, Biotechnology Progress CrossRef - NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives
Remy Thomas et al, 2018, Frontiers in Immunology CrossRef - Nature of tumour rejection antigens in ovarian cancer
Muzamil Y. Want et al, 2018, Immunology CrossRef - Treatment with decitabine induces the expression of stemness markers, PD-L1 and NY-ESO-1 in colorectal cancer: potential for combined chemoimmunotherapy
Nassiba Taib et al, 2023, Journal of Translational Medicine CrossRef - Case-Control Study: Smoking History Affects the Production of Tumor Antigen–Specific Antibodies NY-ESO-1 in Patients with Lung Cancer in Comparison with Cancer Disease–Free Group
Dagmar Myšíková et al, 2017, Journal of Thoracic Oncology CrossRef - Expression and immunogenicity of NY-ESO-1 in colorectal cancer
Ya Li et al, 2017, Experimental and Therapeutic Medicine CrossRef - Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy
Afsheen Raza et al, 2020, Journal of Translational Medicine CrossRef